Handelsbanken Fonder
CLBT icon

Handelsbanken Fonder’s Cellebrite CLBT Stock Holding History

Handelsbanken Fonder’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-975,000
Closed -$13.4M – 1502
2026
Q1 		$13.4M Sell
975,000
-535,000
-35% -$8.06M 0.04% 316
2025
Q4 		$27.2M Sell
1,510,000
-1,390,000
-48% -$25M 0.08% 210
2025
Q3 		$53.7M Buy
2,900,000
+450,000
+18% +$7.07M 0.17% 113
2025
Q2 		$39.2M Buy
2,450,000
+931,300
+61% +$16.6M 0.14% 141
2025
Q1 		$29.5M Buy
1,518,700
+1,340,000
+750% +$28.2M 0.12% 165
2024
Q4 		$3.94M Buy
+178,700
New +$3.44M 0.02% 476

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CS
Central Securities New York $1.34B AUM 21.03% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $27.8B AUM 39.42% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return

Handelsbanken Fonder's CLBT Position: Q2 2026 in Review

Handelsbanken Fonder sold out of Cellebrite (CLBT) in Q2 2026, closing a stake of 975,000 shares — an estimated $13.4M sold.

Handelsbanken Fonder first reported a position in CLBT in Q4 2024 and held it in 6 quarters. The position peaked at $53.7M in Q3 2025. 86 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Handelsbanken Fonder reported no remaining Cellebrite position as of Q2 2026 after selling out during the quarter.
  • Handelsbanken Fonder sold 975,000 Cellebrite shares in Q2 2026, an estimated $13.4M.
  • Handelsbanken Fonder first reported a position in Cellebrite in Q4 2024 and held it in 6 quarters.
  • Handelsbanken Fonder's Cellebrite position peaked at $53.7M in Q3 2025.
  • 86 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Handelsbanken Fonder's 13F filing for Q2 2026, filed 10 Jul 2026.